
Lancet retracts former SickKids pediatrician’s report on infant’s death from opioid poisoning – Retraction Watch

The Lancet has retracted a 20-year-old case report of an infant’s death from opioid poisoning via breast milk, following an institutional investigation that concluded the authors falsified the report by omitting key data.
The 2006 report described the death of a little boy whose mother was prescribed Tylenol with codeine, an opiate that is metabolized to morphine in the body. The report’s first author, pharmacologist Gideon Koren of Toronto’s Hospital for Sick Children, used the case to argue for years that codeine, which is metabolized to morphine in the body, can pose a deadly risk to breast-fed infants.
This claim has been the subject of numerous articles in journals and the media, alongside scrutiny and investigation of Koren’s other work. In January, an article in the New Yorkers brought renewed attention to Koren and the case report, and led a former Ph.D. Koren student to come forward with new allegations on the case report. A look of concern followed.
“On January 20, 2026, The Lancet was contacted with new allegations” that “important toxicological data had been omitted from the paper,” a spokesperson for The Lancet told Retraction Watch via email. This data included the concentrations of codeine and acetaminophen in the infant’s blood, as well as the contents of the baby’s stomach.
The newspaper referred the allegations to the hospital. “SickKids conducted a formal investigation that included newly presented evidence,” a hospital spokesperson said in a statement, “and concluded that important toxicology data had been omitted from the published report and that these omissions could lead readers to not have the necessary information to evaluate the publication’s conclusion.”
The spokesperson declined to provide additional details, but “the report concluded that this omission constitutes falsification,” the retraction notice said. Based on this observation, The Lancet retracted the case report.
The case has been cited 464 times, according to Clarivate’s Web of Science. It has served as a central piece of evidence in guidelines and recommendations for opioid prescriptions for women who have recently given birth, including a 2017 drug safety announcement by the U.S. Food and Drug Administration recommending against prescribing codeine for pain relief in breastfeeding women. Of the 19 articles cited in support of this recommendation, Koren was the author of seven of them, including the now-retracted case report.
“This is the founding document of an entire branch of pediatric pharmacology that was invented from scratch,” pharmacologist David Juurlink, professor of medicine and pediatrics at the University of Toronto, told Retraction Watch. “There is critical information, the levels of acetaminophen and codeine in this baby, that were not in the original publication. If they had been, it would have been obvious from day one that the interpretation was wrong.”
Koren resigned from the Hospital for Sick Children in 2015 following an investigation into Motherisk, a lab he founded that tested for perinatal drug and alcohol exposure, including in criminal and child welfare cases. The investigation, motivated by media coverage of Toronto Starfound that Motherisk lab test results were “inadequate and unreliable,” the newspaper reported. As a result of the investigation, more than 400 of Koren’s documents were reviewed by the hospital.
Koren already has six retractions, two of which were articles about the safety of codeine while breastfeeding.
For more than a decade, Juurlink has been one of the most vocal critics of the idea that breast milk from a mother taking codeine could be toxic to her baby. In 2020, he and pharmacologist Jonathan Zipursky published a review highlighting the unlikelihood of morphine toxicity through breast milk. They calculated that the concentration of morphine in a sample of the mother’s breast milk was relatively low and that the baby had a blood concentration of codeine – not morphine – 100 times higher than expected in breast milk.
This 2020 review resulted in coverage in the Star and a request for withdrawal to The Lancet. as well as requests for retractions of the articles Koren had written about the affair in Canadian family doctor And Canadian Pharmacists Review. The two Canadian journals consulted two external experts and ultimately decided to retract the articles, based on “clear evidence that the results are unreliable,” the joint retraction statement said.
The case received renewed attention in January this year and was the subject of an article in the New Yorkerswhich discussed autopsy data and other evidence indicating that someone was giving the baby painkillers directly rather than through breast milk.
The article also discussed a second case report, “Baby boy blue”, published in Pediatrics and child health by Koren and his colleague Michael Rieder, the only other published case report of possible opioid poisoning via breast milk. The magazine article described a meeting in which Rieder told Juurlink that the affair was made up. Following requests for information from Pediatrics and child healththe journal issued a correction to “Baby boy blue” – and 137 other case reports – to indicate that they were all fictitious.
Parvaz Madadi, former doctoral student. student in Koren’s lab, was a frequent co-author with Koren of studies on codeine and breastfeeding, including lead author of the two Canadian journal articles that were retracted. Madadi recently reviewed his previous work and the 2006 case report, the New Yorkers reported, and in January she wrote to The Lancet alleging that Koren falsified the infant’s toxicology data in the case report and asked the newspaper to remove it. We have contacted her for comment on the retraction.
Like the retractable watch? You can make a tax-deductible contribution to support our workFollow us on or Bluesky, like us on Facebookfollow us on LinkedIn, add us to your RSS readeror subscribe to our daily summary. If you find a retraction, it is not in our databaseyou can let us know here. For comments or feedback, email us at (email protected).
Related
Gn Health